Come up with a name for your new list and we'll add to it:
Pulmotect raised a round of funding on April 14, 2016. Investors include
Fannin Innovation Studio.
Pulmotect is a bio-pharmaceutical company that develops products (host-directed/pathogen-agnostic) to reduce morbidity and mortality in patients at risk of severe respiratory diseases.…